1. Vaccination clinics
   
2. COVID-19 Pfizer (COMIRNATY) 5 to <12 years of age vaccine
   
3. COVID-19 Pfizer (COMIRNATY) adult/adolescent vaccine
   
4. COVID-19 AstraZeneca (ChAdOx1-S) vaccine
5. COVID-19 Moderna (Spikevax) vaccine
6. Consent form
7. Contraindication form
8. Adverse Events
9. COVID-19 vaccination clinics: Job action sheets
10. Training resources

Vaccination clinics

These are supporting documents for the NSW Health Policy Directive PD2021_048 - Standard operating procedure for administration of COVID-19 vaccines in NSW vaccination clinics (updated 21 December 2021).

• NSW Health Policy Directive PD2021_049 - State-wide protocol for the supply or administration of COVID-19 vaccine
  Updated 22 December 2021
• Vaccination worker eligibility for health practitioner students
• COVID-19 vaccination – ATAGI clinical guidance on COVID-19 vaccine in Australia in 2021
• COVID-19 vaccination – ATAGI immunisation provider guide to obtaining informed consent for COVID-19 vaccine
• Anaphylaxis after vaccination
  Published 19 February 2021.
• Managing multiple COVID-19 vaccines at the same site
  
• Transportation of COVID-19 vaccines
  
• Australian Government Department of Health - COVID-19 vaccine - Clinical considerations

Authorities and licences

• Authority to Supply Poisons and Restricted Substances – Authorised health practitioners and health practitioner students
  Updated 16 December 2021.
• Authority to Supply Poisons and Restricted Substances – Defence Medical Technician
  Published 16 April 2021.
• Authority to Supply Poisons and Restricted Substances – Authorised Nurse Immunisers
  Published 19 February 2021.
• Authority to Supply Poisons and Restricted Substances – Authorised person employed by Aspen Medical
  Published 20 September 2021.
  
• Licence to supply by wholesale certain restricted substances
  Published 15 December 2021.

Consent form

• Third primary dose COVID-19 vaccination consent and declaration form

Contraindication form

The form below should only be completed by medical practitioners if:

• A person has a medical contraindication to receiving any available COVID-19 vaccine; or
• A person has a medical contraindication to receiving one brand of COVID-19 vaccine and requires evidence for receiving an alternative brand; or
• A person has a temporary medical contraindication to any COVID-19 vaccine (note, this exemption is only available for a maximum of 6 months at which time the form needs to be recompleted if the condition persists). Examples include:
• Significant immunocompromise
• Recent history of SARS-CoV-2 infection (PCR confirmed)
• Acute medical illness.

If a person has had COVID-19 and has fully recovered, there is no need to delay vaccination. The medical clearance notice provided to the person can be used as a temporary exemption from vaccination for 6 weeks only.

Medical practitioners should consult the latest ATAGI clinical guidance for further information on medical contraindications:

For use by medical practitioners:

• Australian Immunisation Register immunisation medical exemption form
• NSW COVID-19 vaccine medical contraindication form
  

Adverse events

AEFI reporting

• COVID-19 vaccine: Enhanced surveillance and adverse event reporting guidelines
  Updated 23 May 2021.
• National Adverse Events Following Immunisation (AEFI) reporting form
• COVID-19 vaccine: NSW Health adverse event following immunisation case notification form
  Updated 24 February 2021.

AEFI management

• Investigations to support the clinical diagnosis of anaphylaxis following COVID-19 vaccination
  Published 19 February 2021.
• Clinical guidance and testing for suspected Vaccine Induced Prothrombotic Immune Thrombocytopenia (VIPIT) (Thrombosis with thrombocytopenia syndrome)
  Updated 24 April 2021
• Patient information on AstraZeneca vaccine and thrombosis with thrombocytopenia syndrome
  Published 11 April
• Joint statement from ATAGI and THANZ on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca
  Published 23 May 2021
• COVID-19 vaccine: Enhanced surveillance and response to a temporally associated death following vaccination
  Updated 22 February 2021.

COVID-19 vaccine safety surveillance

• Therapeutic Goods Administration - COVID-19 vaccine weekly safety report
• AusVaxSafety - COVID-19 vaccines

COVID-19 vaccination clinic: Job action sheets

Training resources

Training modules are available for clinical staff including:

• Vaccine storage and cold management modules – visit HETI
• NCIRS Shoulder injury related to vaccine administration (SIRVA) presentation
• Melbourne Vaccine Education Centre (MVEC) Vaccination procedures eLearning module
• Anaphylaxis after vaccination – job aid

A multi-dose vial training module will be made available soon.

More information

• For information about other NSW vaccination programs, refer to Immunisation programs.
• For information for COVID-19 vaccination providers at general practices, GP-led respiratory clinics, Aboriginal and Community Controlled Health Services and community pharmacies, visit the Australian Government Department of Health.